Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Adil Zamani"'
Autor:
Esma KEPENEK KURT, Bahar KANDEMİR, İbrahim ERAYMAN, Hülya VATANSEV, Adil ZAMANİ, Şebnem YOSUNKAYA, Soner DEMİRBAŞ, Celalettin KORKMAZ, Pınar Diydem YILMAZ, Necdet POYRAZ, Bahadır FEYZİOĞLU, Mehmet ÖZDEMİR, Mehmet UYAR, Tevfik KÜÇÜKKARTALLAR
Publikováno v:
Mediterranean Journal of Infection, Microbes and Antimicrobials, Vol 10, Iss 1 (2021)
Introduction: The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection is a pandemic, a major global health concern. In this study, it was aimed to compare the clinical, laboratory and computed tomography (CT) findings of patients w
Externí odkaz:
https://doaj.org/article/d1af228c40bf4bc28f466993d8546f29
Publikováno v:
Pakistan Journal of Medical Research, Vol 60, Iss 3 (2021)
Leiomyosarcomas (LMS) are rare tumors of the gastrointestinal (GI) tract with aggressive and poor prognosis. LMS metastasizes primarily to the liver but rarely to the lungs, and has hematogenous spreading from smooth muscle cells of the intestinal wa
Externí odkaz:
https://doaj.org/article/78d496715f3a41608420507558d8a26d
Publikováno v:
Journal of International Medical Research, Vol 48 (2020)
Objective To investigate the effects of pulmonary rehabilitation (PR) and combined nutritional support therapy on quality of life (QoL) and functional status in patients with chronic obstructive pulmonary disease (COPD). Methods This pre-and post-int
Externí odkaz:
https://doaj.org/article/e6e1e9fa4b2f43cf91e9eaebcd1720d9
Autor:
Gulfidan Bitirgen, Celalettin Korkmaz, Adil Zamani, Mehmet Sinan Iyisoy, Hurkan Kerimoglu, Rayaz A. Malik
Publikováno v:
International Ophthalmology. 42:2847-2854
To characterize alterations in pupillary light reflex responses in subjects following coronavirus disease 2019 (COVID-19), especially those with long-COVID.Thirty-five subjects with previous COVID-19 and 30 healthy control participants were enrolled
Autor:
Hulya Vatansev, Mehmet Ali Karaselek, Serkan Kuccukturk, Soner Demirbas, Ozcan Ceneli, Bulent Isik, Kazim Camli, Celalettin Korkmaz, Sebnem Yosunkaya, Adil Zamani, Turgut Teke
Publikováno v:
Selcuk Tip Dergisi.
Amaç: Corona Virüs 2019 Hastalığı (COVID-19)’nda şu ana kadar spesifik antiviral ajan olmamasına rağmen tedavi için konvelesan plazma (CP) tedavisi tedavi için kullanılmıştır. Ancak CP tedavisinin prognoz ve mortalite üzerindeki etki
Autor:
Ahmet Ozkagnici, Nazmi Zengin, Rayaz A. Malik, Georgios Ponirakis, Adil Zamani, Gulfidan Bitirgen, Celalettin Korkmaz
Publikováno v:
The British Journal of Ophthalmology
Background/AimsLong COVID is characterised by a range of potentially debilitating symptoms which develop in at least 10% of people who have recovered from acute SARS-CoV-2 infection. This study has quantified corneal sub-basal nerve plexus morphology
Autor:
Necdet Poyraz, Hülya Vatansev, Şebnem Yosunkaya, Pinar Diydem Yilmaz, Adil Zamani, Mehmet Uyar, Turgut Teke, Soner Demirbaş, Celalettin Korkmaz
Publikováno v:
Online Türk Sağlık Bilimleri Dergisi. 6:251-261
Objective: To investigate neutrophil/lymphocyte (NLR), lymphocyte/monocyte (LMR), platelet/lymphocyte (PLR) ratios, and the value of these parameters in determining disease severity and progression in hospitalized COVID-19 patients. Materials and Met
Publikováno v:
Turkish Journal of Medical Sciences
Background/aim We aimed to evaluate the prevalence of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease (COPD). Materials and methods This cross-sectional study was performed on 219 patients aged 50 years and o
Autor:
Adil Zamani, Eray Yıldız, Fatih Çölkesen, Gökhan Aytekin, Ahmet Zafer Çalışkaner, Şevket Arslan
Publikováno v:
Asthma Allergy Immunology. 18:91-97
Objective: Bronchiectasis is a chronic debilitating disease of the airways that results in chronic cough and production of viscous sputum due to dilatation of the airways and bronchial wall thickening. Although bronchiectasis is a common problem in i
Publikováno v:
Indian journal of cancer. 59(2)
Mutations in the RAS genes, HRAS, KRAS, and NRAS, are the most common modifications in many types of human tumors and are found in approximately 30% of all human cancers. These mutations are usually found in codons 12, 13, or 61.The aim of this study